Search Results - "Kasprzyk, Philip G"
-
1
In Vitro Evaluation of the Potential for Drug Interactions by Salidroside
Published in Nutrients (25-08-2023)“…Several studies utilizing Rhodiola rosea, which contains a complex mixture of phytochemicals, reported some positive drug-drug interaction (DDI) findings based…”
Get full text
Journal Article -
2
Safety of a Sustainably Produced, Bioengineered, Nature-Identical Salidroside Compound
Published in Nutrients (01-06-2022)“…Bioactive phytochemicals such as salidroside have been studied to understand the beneficial effects of , an herbaceous plant used in traditional medicine to…”
Get full text
Journal Article -
3
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice
Published in PloS one (06-12-2013)“…Despite paclitxael's clinical success, treating hormone-refractory breast cancer remains challenging. Paclitaxel has a poor pharmacological profile,…”
Get full text
Journal Article -
4
IRC‐083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells
Published in International journal of cancer (15-03-2009)“…CDC25 phosphatases are key actors in cyclin‐dependent kinases activation whose role is essential at various stages of the cell cycle. CDC25 expression is…”
Get full text
Journal Article -
5
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
Published in Journal of medicinal chemistry (08-02-2018)“…Quinazolinone-based anticancer agents were designed, decorated with functional groups from a 2-methoxyestradiol-based microtubule disruptor series,…”
Get full text
Journal Article -
6
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
Published in Molecular cancer therapeutics (01-09-2005)“…Cell cycle regulators, such as the CDC25 phosphatases, are potential targets for the development of new anticancer drugs. Here we report the identification and…”
Get full text
Journal Article -
7
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents
Published in Molecular cancer therapeutics (01-08-2008)“…Tubulin is a validated target for antitumor drugs. However, the effectiveness of these microtubule-interacting agents is limited by the fact that they are…”
Get full text
Journal Article -
8
3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol Derivatives: Synthesis, In Vitro and In Vivo Anticancer Activity
Published in Journal of medicinal chemistry (06-09-2007)“…Estradiol-3,17-O,O-bis-sulfamates inhibit steroid sulfatase (STS), carbonic anhydrase (CA), and, when substituted at C-2, cancer cell proliferation and…”
Get full text
Journal Article -
9
Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors
Published in ChemMedChem (01-01-2014)“…A structure–activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)‐based steroidomimetic and chimeric…”
Get full text
Journal Article -
10
Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1-Substituted Tetrahydroisoquinolines
Published in ChemMedChem (01-02-2014)“…The syntheses and antiproliferative activities of novel substituted tetrahydroisoquinoline derivatives and their sulfamates are discussed. Biasing of…”
Get full text
Journal Article -
11
Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric G alpha /G beta gamma Protein Complex
Published in Cancer research (Chicago, Ill.) (15-09-2006)“…A large number of hormones and local agonists activating guanine-binding protein-coupled receptors (GPCR) play a major role in cancer progression. Here, we…”
Get full text
Journal Article -
12
Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval
Published in Molecular pharmacology (01-02-2005)“…Most drugs currently used for human therapy interact with proteins, altering their activity to modulate the pathological cell physiology. In contrast,…”
Get more information
Journal Article -
13
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Gα/Gβγ protein complex
Published in Cancer research (Chicago, Ill.) (15-09-2006)“…A large number of hormones and local agonists activating guanine-binding protein-coupled receptors (GPCR) play a major role in cancer progression. Here, we…”
Get full text
Journal Article -
14
Cover Picture: Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors (ChemMedChem 1/2014)
Published in ChemMedChem (01-01-2014)“…A structure-activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)-based steroidomimetic and chimeric…”
Get full text
Journal Article -
15
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
Published in Breast cancer research and treatment (01-09-2008)“…Breast cancer is the leading cause of cancer deaths among women worldwide. The theory of targeting both cancer cells directly and their blood supply has…”
Get full text
Journal Article -
16
A novel synthetic inhibitor of CDC25 phosphatases: BN82002
Published in Cancer research (Chicago, Ill.) (01-05-2004)“…CDC25 dual-specificity phosphatases are essential regulators that dephosphorylate and activate cyclin-dependent kinase/cyclin complexes at key transitions of…”
Get full text
Journal Article -
17
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Published in Journal of medicinal chemistry (31-12-1998)“…Homocamptothecin (hCPT), a camptothecin (CPT) analogue with a seven membered β-hydroxylactone which combines enhanced plasma stability and potent topoisomerase…”
Get full text
Journal Article -
18
-
19
IIn Vitro/I Evaluation of the Potential for Drug Interactions by Salidroside
Published in Nutrients (01-08-2023)“…Several studies utilizing Rhodiola rosea, which contains a complex mixture of phytochemicals, reported some positive drug-drug interaction (DDI) findings based…”
Get full text
Journal Article -
20
Recombinant Anti-ErbB2 Immunotoxins Containing Pseudomonas Exotoxin
Published in Proceedings of the National Academy of Sciences - PNAS (01-07-1992)“…Immunotoxins were made using five different murine monoclonal antibodies to the human erbB2 gene product and LysPE40, a 40-kDa recombinant form of Pseudomonas…”
Get full text
Journal Article